Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children
ConclusionsThese findings provide novel biomarkers in urine that are easy to translate into clinical diagnosis of RMS and illustrate the value of global and targeted urine proteomics to identify and qualify candidate biomarkers for noninvasive molecular diagnosis.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research
More News: Biochemistry | Brain | Chemotherapy | Children | Genetics | Molecular Biology | Neurology | Neurosurgery | Rhabdomyosarcoma | Sarcomas | Soft Tissue Sarcoma